The QualityStocks Daily Wednesday, August 8th, 2018

Today's Top 3 StockMarketWatch

StockMarketWatch (ABIL) +124.49%

QualityStocks (ATHC) +38.46%

Planet Penny Stocks (SGSI) +36.00%

The QualityStocks Daily Stock List

Mikros Systems Corp. (MKRS)

Promotion Stock Secrets, PennyStockRumors, OTCEquity, PennyStocks24, AwesomeStocks, Wall Street Mover, PricelessPennyStocks, StockRockandRoll, Fast Money Alerts, Actual Gains, Marketbeat, AddictivePennyStocks, Chatter Box Stocks, StockLockandLoad, StockBomb, ResearchOTC, and OTPicks reported on Mikros Systems Corp. (MKRS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Mikros Systems Corp. is a provider of advanced maintenance and monitoring solutions for mission-critical systems. The Company is an advanced technology enterprise, which designs and manufactures specialized electronic systems for the Department of Defense. Its chief business is to pursue and obtain contracts from the Department of Homeland Security, the U.S. Navy, and other governmental authorities. Mikros Systems is headquartered in Princeton, New Jersey. It has its Manufacturing and Depot Center in Largo, Florida.

Mikros’ capabilities include technology management, electronic systems engineering and integration, radar systems engineering, command, control, communications, computers and intelligence systems engineering, and communications engineering.

The Company produces advanced maintenance systems for the Navy. These include the ADEPT Maintenance Automation Workstation and the ADSSS Condition Based Maintenance system for the Littoral Combat Ship. ADEPT systems are in use daily for performance optimization of advanced radar systems.

Mikros Systems’ Lifecycle Support capability is focused on ensuring the systematic interactions between Integrated Logistics Support (ILS), Depot, and Field Support activities are integrated to achieve the highest levels of system readiness. The Company purchased certain software products, intellectual property (IP) and related assets from VSE Corp. The main software programs purchased by Mikros are the Prognostics Framework (PF) and Diagnostic Profiler (DP) programs.

The Diagnostic Profiler software is used globally by many multinational companies for optimized maintenance of varied product lines. Also, Diagnostic Profiler is used by the U.S. Air Force for depot test programs.

Prognostics Framework is used by the U.S. Army for numerous missile defense systems. These software products provide Mikros Systems with the opportunity to service commercial customers and additional Department of Defense customers outside the Navy.

Recently, Mikros announced it received a follow-on $2.5 million contract from the U.S. Navy to continue to develop its Condition-Based Maintenance (CBM) systems for the Navy's MK 99 Fire Control System (FCS). Mikros is developing a new variant of its ADSSS system.

This new contract award encompasses continued development, at-sea testing, and validation of the system.  Under the contract, Mikros Systems’ CBM technology will be utilized for the first time in the Navy's Aegis surface combatant fleet of destroyers and cruisers.

The ADSSS system recently received official Navy nomenclature as the AN/SYM-3. It is presently used on the Navy's Littoral Combat Ship (LCS) to monitor two other radars and combat system elements.  The new variant of the SYM-3, which will monitor the Director in the MK 99 system, has been in development since 2017.

Mikros Systems Corp. (MKRS), closed Wednesday's trading session at $0.51, even for the day, on 100 volume with 1 trade. The average volume for the last 60 days is 25,824 and the stock's 52-week low/high is $0.30/$0.57.

chart

Strategic Environmental & Energy Resources, Inc. (SENR)

Streetwise Reports, CapitalCube, Wallet Investor, Marketbeat, GuruFocus, and Simply Wall St reported on Strategic Environmental & Energy Resources, Inc. (SENR), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Strategic Environmental & Energy Resources, Inc. (SENR) is a provider of environmental, renewable fuels and industrial waste stream management services. The Company has three wholly-owned operating subsidiaries. These are REGS, LLC; MV Technologies, LLC, and SEER Environmental Materials, LLC. SENR is based in Golden, Colorado and the Company lists on the OTCQB.

SENR works for either destroying/minimizing hazardous waste streams more safely and at lesser cost than any competitive alternative, and/or processing the waste for use as a renewable fuel for the benefit of customers and the environment.

The Company is strategically shifting to a dedicated environmental technology business. It also has two majority-owned subsidiaries. These are Paragon Waste Solutions, LLC; and ReaCH4biogas (Reach).

In essence, SENR identifies, secures, and commercializes patented and proprietary environmental clean technologies in numerous multibillion dollar sectors. These sectors include oil & gas, renewable fuels, and all kinds of waste management, solid and gaseous.

The Company provides environmental, renewable fuels, and industrial waste stream management services to oil producers and refiners, railcar operators, industrial and manufacturing companies, medical facilities, government agencies, universities and environmental consulting firms. SENR’s customers engage the Company to manage initiatives ranging from improving operating efficiencies to EPA (Environmental Protection Agency) compliance to creation of renewable fuels.

Concerning Odor/Emissions Control & Renewable Fuels, SENR’s MV Technologies is an engineering/technology business. MV designs and provides odor, vapor, and emission control systems for different sectors.

Regarding Waste Destruction, Paragon Waste Solutions is at the technological vanguard of the waste management and destruction industry. Paragon Waste Solutions’ patent-pending CoronaLux™ system utilizes a low-energy, plasma-enhanced pyrolytic process to safely and reliably destroy hazardous, chemical, biological (military de-weaponization), pharmaceutical, and regulated medical waste.

Concerning Industrial/Environmental solutions, SENR’s solutions portfolio includes services for environmental regulation and compliance, upstream/downstream oil and gas operations, wastewater treatment, dewatering/centrifuging, railcar and tank cleaning, and general waste handling and minimization services.

REGS, an industrial cleaning subsidiary of SENR, has been awarded a new cleaning project for a large steel company in Pueblo, Colorado. This project will comprise tank cleaning and a number of ancillary activities. These include ultra-high-pressure water cutting and vacuum truck services. The anticipation is that the project will generate about $0.5 million in revenue.

Strategic Environmental & Energy Resources, Inc. (SENR), closed Wednesday's trading session at $0.1925, down 3.75%, on 1,862 volume with 2 trades. The average volume for the last 60 days is 20,090 and the stock's 52-week low/high is $0.161/$0.79.

chart

American Lithium Corp. (LIACF)

StreetAuthority Financial, Dynamic Wealth Research, Investor Spec Sheet, Market FN, Wall Street Mover, Morningstar, SmallCapVoice, OTC Markets Group, Penny Stock Rumble, InvestmentHouse, Investors Insights, MicroCap Gems, Oakshire News Bulletin, and The Best Newsletters reported on American Lithium Corp. (LIACF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

American Lithium Corp. engages in the acquisition, exploration, and development of lithium deposits within mining-friendly jurisdictions across the Americas. The Company’s Fish Lake Valley lithium brine properties are about 38 kilometers from Albemarle's Silver Peak (the largest lithium producer in the U.S). OTCQB-listed, American Lithium is based in Vancouver, British Columbia.

The Company holds options to acquire Nevada lithium brine claims totaling 22,332 acres (9,038 hectares). This includes 18,552 contiguous acres (7,508 hectares) in Fish Lake Valley, Esmeralda County; and the 2,240-acre (907-hectare) San Emidio project in Washoe County.

Fish Lake Valley is one of the most promising and largely undeveloped lithium brine basins in Nevada. Its geological and geophysical characteristics are similar to the Clayton Valley basin positioned to the southeast. 

The Q2-2016 acquisition of the Fish Lake Valley land package includes the North and South Bowl Playas. The acquisition covers all important structures of the North and South Bowl Playas, which contain the lithium brines, and where gravity data shows distinct gravity lows.

The San Emidio Project is 60 miles (100 km) northeast of Reno - home to Tesla's Gigafactory. Lithium concentrations in brines at San Emidio are reasonably expected to increase at depth. This is also the case at Clayton Valley. A gravity geophysical survey indicates a previously discovered near surface lithium brine anomaly on the west side of basinal low. Anomalous lithium values were detected during brine sampling. The highest value was 80 mg/L.

American Lithium is expanding its existing holdings in Fish Lake Valley, Esmeralda County. The Company is already the dominant land holder in the Valley, with 18,552 contiguous acres under management. It recently entered into an agreement to acquire an additional 3,575-acre parcel in the Valley, comprising 167 contiguous claims named the Gap-Lode Project. The Project overlies 2,480 acres of public land. The Gap-Lode Project is neighbouring an existing 1,094-acre claim block.

In June, American Lithium started an integrated geologic and geochemical study of the Gap-Lode project to identify and prioritize target zones for auger sampling, trenching, as well as drilling. As of July 16, 2018, Company field crews were onsite surface trenching and mapping the extent of outcropping lithium claystones.

American Lithium Corp. (LIACF), closed Wednesday's trading session at $0.3554, down 6.42%, on 10,270 volume with 10 trades. The average volume for the last 60 days is 6,113 and the stock's 52-week low/high is $0.1315/$0.40.

chart

Bravada Gold Corp. (BGAVF)

Gold Investment Letter and Real Pennies reported earlier on Bravada Gold Corp. (BGAVF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Bravada Gold Corp. is a Nevada-focused exploration and development company. It has a large portfolio of high-quality properties. These properties encompass a range of development stages. This is from early-stage exploration to advanced-stage exploration and pre-development. Bravada Gold is based in Vancouver, British Columbia. The Company’s shares trade on the OTC Markets Group’s OTCQB.

Bravada Gold retains residual working or royalty interests. The Company explores for precious metals in well-established gold trends in one of the globe’s best gold jurisdictions. At present, five of its Nevada properties are being funded by partners. In total this includes earn-in work expenditures of up to $6.5 million and payments to Bravada Gold of up to +$3.0 million in cash and shares. Bravada holds a royalty on eventual barite production on its Shoshone Pediment Project.

Regarding its Wind Mountain project, the Company’s plan is to drill-test for high-grade “Hishikari-type” gold/silver vein mineralization beneath the existing disseminated resource at Wind Mountain. Concerning the SF property, Bravada plans to drill-test for high-grade “Carlin-type” gold mineralization at this property.

Pertaining to the North Lone Mountain and South Lone Mountain projects, plans have not been finalized for Bravada Gold’s two claim groups. However, Nevada Zinc continues to expand the footprint of zinc mineralization on its claims towards Bravada’s South Lone Mountain claims. Should Nevada Zinc complete the purchase of these claims, Bravada will retain a royalty on base and precious metals.

This past December, Bravada Gold announced that drilling is underway at its 100 percent owned low-sulfidation Wind Mountain project. Two reverse-circulation holes are planned, one roughly 450m deep and the other roughly 750m deep. The design of the holes is to be proof-of-concept holes. More holes may be added depending on drilling costs and results. The Wind Mountain Project is the Company’s past-producing gold/silver property in north-western Nevada.

Last month, Bravada Gold reported that two proof-of-concept holes were completed in December and early January at the Wind Mountain Project. The reverse-circulation holes were drilled about 1,500m apart.

Alteration and geochemistry indicate that the southerly hole intersected mineralization with characteristics of being up-dip from a feeder zone. In addition, the northerly hole intersected characteristics of being down-dip from a feeder zone. This indicates that the feeder lies between these holes. Each hole intersected a low-angle fault, which separates the Tertiary volcanic and sedimentary host rocks from Mesozoic metamorphosed basement rocks.

Recently, Bravada Gold announced that it received notice that Coeur Explorations, Inc. elected to relinquish its option to purchase Bravada's interest in the Quito property positioned along the Austin Gold trend in central Nevada. Since July of 2015 Coeur Explorations has been funding Bravada Gold, as Operator, in the conduct of exploration at Quito, with recent focus upon completion of permitting to allow drilling this year at the Quito Extension target.

This target was developed during the 2016 exploration program. Around US$600,000 has been received by Bravada Gold by way of this funding, which has been credited to its earn-in obligations to earn its interest in Quito.

Mr. Joe Kizis, Bravada Gold President, said, "Exploration work funded by Coeur has greatly advanced Quito to a 'drill-ready' stage. Bravada will continue to permit four drill sites and plans to drill 4 to 6 holes for 1,600m beginning in the third quarter of 2018 with the intent to test the down-plunge extension of the high-grade mineralization that occurs along the intersection of two primary faults and several secondary faults; this target has not been tested to depth."

Bravada Gold Corp. (BGAVF), closed Wednesday's trading session at $0.0703, up 32.64%, on 18,866 volume with 4 trades. The average volume for the last 60 days is 37,890 and the stock's 52-week low/high is $0.0524/$0.1699.

chart

Alliance BioEnergy Plus, Inc. (ALLM)

Stocks That Move reported earlier on Alliance BioEnergy Plus, Inc. (ALLM), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Alliance BioEnergy Plus, Inc. focuses on the commercialization and licensing of a patented cellulose conversion technology. It controls this technology through a master license agreement with the University of Central Florida. Alliance BioEnergy Plus’s subsidiaries focus on developing technologies in the renewable energy, bio-fuels, as well as new technologies sectors. OTCQB-listed, Alliance BioEnergy Plus is headquartered in West Palm Beach, Florida.

The Company operates various subsidiaries. AMG Energy Group, LLC owns 50 percent of Carbolosic, LLC (in a joint venture (JV) with Thor Renewable Energy Singapore) and exclusively the territories of North America and Africa. Carbolosic holds the exclusive worldwide license for the patented CTS™ (Cellulose to Sugar) process, developed and owned by the University of Central Florida.

Carbolosic holds the exclusive, worldwide license to four issued patents and 14 filed and pending patents revolving around the core CTS (cellulose to sugar) technology.

The CTS™ process converts cellulose into commercial grade sugars, fine chemicals, and other highly valuable products. Alliance BioEnergy Plus’s intention is to center on the production of these commercial products by way of company-owned and licensed facilities

The Company’s commercial pilot/demonstration and research facility, Ek Laboratories, LLC, came online in early 2015. Under the direction of CTS™ inventor Dr. Richard Blair, the facility is running the CTS process, at a commercial scale, and is providing licensees with real time analytics.

The AMG Energy Group subsidiary was created to be the technology arm of the Company. AMG concentrates on the licensing of Alliance BioEnergy Plus’s Intellectual Property (IP), engineering and construction of CTS plants, and developing technologies in the renewable energy, bio-fuels, and new technology sectors.

The CTS Cellulose Ethanol technology can produce a high quality, clean burning Ethanol from almost any plant material less costly, faster, and without any hazardous inputs. The Company has completed the construction of its commercial scale CTS demonstration plant and research laboratories at its subsidiary Central Florida Institute of Science and Technology, Inc. (CFIST).

Alliance BioEnergy Plus earlier filed an 8K with the SEC (Securities and Exchange Commission) disclosing that its subsidiary, Alliance Bio-Products, Inc., entered into a material definitive agreement to purchase the closed ethanol facility in Indian River County, Florida.

The Company received approval from the United States Department of Agriculture (USDA) Office of Rural Development (USDA Rural Development) to move ahead with the purchase in early July 2017. The approved purchase, at a price of $8M, includes the fully functional plant, 144-plus acres that the plant resides on, and all related equipment and vehicles.

Recently, Alliance BioEnergy Plus announced that wholly-owned subsidiary, Ek Laboratories, received a six-figure payment from Phoenix Biomaterials Thomaston, LLC, upon their completion of due diligence of the CTS process, for successful feedstock evaluation and also preliminary engineering reports, related to building a Greenfield (new plant from the ground up) CTS plant. Phoenix’s intention is to enter into a sublicense agreement with the Company once they finalize the logistics of their initial site based on the reports purchased from Alliance BioEnergy Plus.

Alliance BioEnergy Plus, Inc. (ALLM), closed Wednesday's trading session at $0.033, up 18.71%, on 463,433 volume with 55 trades. The average volume for the last 60 days is 205,160 and the stock's 52-week low/high is $0.02/$0.2399.

chart

China YCT International Group, Inc. (CYIG)

PennyStockCrowd, Marquee Penny Stocks, Penny Stock Rumble, PennyStocksV2, SquawkBoxStocks, Penny Pick Finders, TerrificPennyStocks, AwesomeStocks, PennyStocks24, Buzz Stocks, Breaking Bulls, Chatter Box Stocks, MyBestStockAlerts, and Planet Pennies reported earlier on China YCT International Group, Inc. (CYIG), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

China YCT International Group, Inc is a developer, manufacturer, as well as distributor of traditional Chinese medicines (TCM). The Company engages in the business of developing, manufacturing, and selling medicine, developing acer truncatum bunge planting bases and manufacturing and selling the seed oil, and distributing healthcare supplement products manufactured by a third party. A diversified company, China YCT International Group is headquartered in Sishui County, Shandong Province, China. The Company lists on the OTC Markets’ OTCQB.

China YCT engages in developing, manufacturing, and selling its own TCM’s made primarily from ginseng extract, manufacturing and distributing acertruncatumbunge seed oils, and distributing the abovementioned health care supplement products in China.

Acer Truncatum is a kind of maple. It has 300 species around the world. The Acer Truncatum oil contains 5.8 percent of nervonic acid. Acer Truncatum is contained in plants, and nervonic acid can undergo extraction from these very economically.

Acer Truncatum is only available in China. After more than four decades research and experiments, the Chinese government approved Acer Truncatum oil as general wood food oil that can be used as a general food oil, such as soybean, corn, olive, and other food oils.

The Company announced in May of 2017 that it signed an agreement to purchase the Acer Truncatum business from Shandong YCT Group Co. Ltd. The expectation is that this new business will boost sales by a billion U.S. dollars for China YCT in the next 5 years.

At the beginning of this month, China YCT International Group announced that Shandong Spring Pharmaceutical Co., Ltd., a 97 percent owned subsidiary of the Company, was ratified and issued a Food Production License for production of edible vegetable oil. This includes acer truncatum bunge seed oil, and related blended edible oil products. The License was granted by the Food and Drug Administration of Sishui County. It is valid for five years.

In addition, this month, China YCT International Group announced its financial results for the three and nine months ended December 31, 2017. Total Revenues rose by 21.4 percent year-over-year to $17.21 million. There was growth in sales across all three product categories - acertruncatumbunge seed oil, health care products, and Huoliyuan capsules.

Overall Gross Margin was 39.4 percent for the three months ended December 31, 2017, versus 41.0 percent for the same period of the previous fiscal year. Net Income attributable to China YCT was $2.78 million, or $0.09 per share, for the three months ended December 31, 2017, versus $2.59 million, or $0.09 per share, for the same period of the previous fiscal year.

China YCT International Group, Inc. (CYIG), closed Wednesday's trading session at $0.55, up 10.00%, on 2,529 volume with 3 trades. The average volume for the last 60 days is 3,844 and the stock's 52-week low/high is $0.25/$1.01.

chart

Gilla, Inc. (GLLA)

Greenbackers, SmallCapVoice, SmallCapFinancialWire, TopPennyStockMovers, Marketbeat, StockBlogs, and Real Pennies reported previously on Gilla, Inc. (GLLA), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Gilla, Inc. manufactures, markets, and distributes E-liquid (the liquid used in vaporizers and E-cigarettes) and other vaping hardware and accessories. The Company’s aim is to be an international leader in delivering the most efficient and effective vaping solutions for nicotine and cannabis related products. Furthermore, Gilla is a developer of cannabis concentrate products.

The Company has its corporate office in Toronto, Ontario. Gilla’s manufacturing facility is in Daytona Beach, Florida.

Gilla's proprietary product portfolio includes Spectrum Concentrates, Coil Glaze™, Craft Vapes™, Siren, The Drip Factory, Shake It, Surf Sauce, Ohana, Moshi, Crisp, Just Fruit, Cassidy's Outlaw Series, Vinto Vape, Vapor's Dozen, Enriched Vapor, and Crown E-liquid™.

In May, Gilla announced its plan to pursue a spin-off of its cannabis-related business to Gilla's shareholders. The expectation is that the transaction will result in two separate public companies, which will benefit from separating their respective corporate strategies and capital allocation priorities.

Last month, Gilla announced that it entered into a Letter of Intent (LOI) to acquire all of the issued and outstanding shares of TB INVEST BVBA. TB INVEST is a Belgium-based distributor and retailer of E-liquid and other vapor products.

The acquisition of TB INVEST would be a transformative acquisition for Gilla creating a vertically integrated business amalgamating Gilla's worldwide manufacturing platform with TB INVEST's European-centered distribution and retail business.

TB INVEST was formed in Antwerp, Belgium in 2013. Its VaporShop retail brand is among the largest vape store retailers in Europe. VaporShop now has 47 franchised retail locations throughout Belgium in addition to TB INVEST's wholesale and retail distribution network of greater than 400 vendors throughout Europe.

Mr. Graham Simmonds, Chair and Chief Executive Officer of Gilla, said in July, "The acquisition of TB INVEST is a truly transformational opportunity for Gilla as consolidating our global manufacturing and distribution platform with TB INVEST's established wholesale and retail network will launch an exponential growth phase for Gilla. We look forward to utilizing the combined platform to grow our business in new geographies while further strengthening it in countries we already have a presence in."

Gilla, Inc. (GLLA), closed Wednesday's trading session at $0.08, down 11.11%, on 45,750 volume with 4 trades. The average volume for the last 60 days is 23,101 and the stock's 52-week low/high is $0.0501/$0.21.

chart

Golden Predator Mining Corp. (NTGSF)

OTC Markets, Stockhouse, Gold Investment Letter, Junior Mining Network, Barchart, Penny Stock Hub, and The Street reported on Golden Predator Mining Corp. (NTGSF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Golden Predator Mining Corp. acquires and explores for mineral properties in the U.S. and Canada. It centers on its district scale, orogenic gold-in-quartz 3 Aces Project in the Yukon. OTCQX-listed, the Company previously went by the name Northern Tiger Resources, Inc. It changed its name to Golden Predator Mining Corp. in April of 2014. Golden Predator Mining is based in Vancouver, British Columbia.

The 100 percent owned 3 Aces Project is 357 km2 (35,700 hectares). It is a high-grade gold project (Orogenic Gold Model). The 3 Aces Project includes at least 6 mineralized areas. These are all positioned within and along favorable stratigraphic and structural zones, which extend more than 35km along trend.

A number of mineralized veins have been discovered so far. Many have visible gold occurrences. The 3 Aces Project hosts the two highest grade surface outcrops discovered to date in the Yukon.

Additionally, Golden Predator Mining holds 100 percent of the advanced Brewery Creek Project in the Yukon. The Brewery Creek Mine is operated by Golden Predator Mining. The target at the Brewery Creek Mine is an intrusion related gold deposit. The Brewery Creek Mine is 55km east of Dawson in the northwestern area of the Yukon.

Golden Predator Mining announced this past March that it began a 4,000-meter (m) diamond drill program at the 3 Aces Project in southeastern Yukon. The drill program is first concentrating on stepping-out with wide-spaced drilling within the Central Core Area, testing continuity along favorable stratigraphic-structural contacts along the Hearts-Clubs corridor and from the Spades area, now believed to represent the down dip extension of the Hearts-Clubs corridor.

In July, Golden Predator Mining announced it started a 1,500 m diamond drilling program at its 100 percent owned, past-producing Brewery Creek Project in the Yukon to assess the potential for economic enhancement of this former producer; and expansion of the current resource package.  

The drill program will generate large diameter core (PQ) for metallurgical testing to evaluate alternate processing technology.  Moreover, 1,000 m of exploration drilling will be completed on recently identified high priority targets designed to extend known mineralization.

Furthermore, in July, Golden Predator Mining announced a 2,500 m diamond drill program was taking place at the high-grade gold, 100 percent owned Sprogge Area of its 3 Aces Project. Drilling will target the primary structural control along 2 km of strike at varying depths ranging from near surface to approximately 200 m depth. The drill program follows field reconnaissance and historical surface sampling that returned 25 quartz outcrop samples ranging from 5.73 g/t to 46.49 g/t gold along an exposed 2 km of strike.

Golden Predator Mining Corp. (NTGSF), closed Wednesday's trading session at $0.27671, up 1.18%, on 6,320 volume with 8 trades. The average volume for the last 60 days is 45,514 and the stock's 52-week low/high is $0.2514/$0.984.

chart

Premier Gold Mines Limited (PIRGF)

The Street, Stockscores, Stockhouse, Stock Target Advisor, InvestorsHub, The Northern Miner, and TraderPlanet reported on Premier Gold Mines Limited (PIRGF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

A gold producer and exploration and development company, Premier Gold Mines Limited has a high-quality pipeline of precious metal projects. These projects are in proven, accessible and safe mining jurisdictions in the United States, Canada, and Mexico. Premier Gold Mines has its headquarters in Thunder Bay, Ontario. The Company lists on the OTC Markets.

Premier Gold Mines’ team is focused on creating a low‑cost, mid-tier gold producer via its two producing gold mines, and two advanced multi-million-ounce development projects where permitting and pre-construction initiatives are taking place.

The Company’s important North American-based assets are along Nevada's Carlin and Battle Mountain-Eureka Trends and in the Sonora State of Mexico. Its Canadian-based projects explore the Superior Geological Sub-Province of Ontario. This is one of the world’s most richly-endowed mineral regions.

Premier’s production properties are South Arturo and Mercedes. The Company’s advanced exploration & development properties are Greenstone Gold and Cove. Its exploration properties are Rahill-Bonanza, McCoy-Cove, Hasaga, as well as Goldbanks.

Premier Gold Mines has entered into a Nevada-focused exploration and development agreement with Barrick Gold Corporation (ABX), through several wholly-owned subsidiaries.

Recently, Premier Gold Mines provided an update of development programs initiated at its South Arturo Property in the Carlin Trend of Nevada where construction of the Phase 1 open pit and the El Nino underground mine have started.

The South Arturo Property is a joint venture (JV) between Premier Gold Mines (40 percent ownership) and Barrick Gold Corporation's wholly‑owned subsidiary of Barrick Gold Exploration, Inc.

Mr. Ewan Downie, President & Chief Executive officer, said, "With new mine developments being advanced ahead of schedule at South Arturo, the stage is set for a solid operational future at this strategic property. Work continues on several additional opportunities that could add to reserves and resources and provide for sustained mining operations".

Premier Gold Mines Limited (PIRGF), closed Wednesday's trading session at $1.8017, down 3.13%, on 71,505 volume with 109 trades. The average volume for the last 60 days is 51,080 and the stock's 52-week low/high is $1.83/$3.37.

chart

MetaStat, Inc. (MTST)

Goldman Small Cap Research, Innovative Marketing, Club Penny Stocks Network, OTCBB Journal, First Penny Picks, StocksImpossible, Pumps and Dumps, and The MicrocapNews reported previously on MetaStat, Inc. (MTST), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, MetaStat, Inc. is a personalized medicine company developing therapeutic and diagnostic treatment solutions for cancer patients. The Company develops and commercializes diagnostic products and novel therapeutics for the early and reliable prediction and treatment of systemic metastasis - the process by which cancer spreads from a primary tumor through the bloodstream to other areas of the body. MetaStat’s focus is on breast, prostate, lung, and colorectal cancers, where systemic metastasis is responsible for approximately 90 percent of all deaths.

A life sciences company, MetaStat is headquartered in Boston, Massachusetts. In essence, MetaStat’s core expertise includes an understanding of the mechanisms and pathways that drive tumor cell invasion and metastasis, and also drug resistance to certain targeted therapies and cytotoxic chemotherapies.

The basis of MetaStat’s function-based diagnostic platform technology is on the identification and understanding of the vital role of the mena protein and its isoforms (a common pathway for the development of systemic metastatic disease in all epithelial-based solid tumors).

The design of the MetaSite Breast™ and MenaCalc™ product lines are to accurately stratify patients based on their individual risk of metastasis and to enable clinicians to better customize cancer treatment decisions through positively identifying patients with a high-risk of metastasis who need aggressive therapy and by sparing patients with a low-risk of metastasis from the damaging side effects and cost of chemotherapy.

The MetaSite Breast™ test measures the process of systemic metastasis. MenaCalc™, a platform of diagnostic assays, based on the measurement of the balance of the Mena protein isoforms, is widely applicable in solid epithelial-based cancers.

The intention of the MetaSite Breast™ test is for use in patients with early stage (stage 1-3), invasive breast cancer who have node-negative or node positive (1-3), estrogen receptor-positive, HER2-negative disease.

In August of 2017, MetaStat announced that accomplished drug developer, Renato T. Skerlj, Ph.D., joined the Company as a member of its Scientific and Clinical Advisory Board. Dr. Skerlj has more than 25 years of pharmaceutical experience in drug development resulting in two marketed drugs: Invanz® and Mozobil® and numerous drugs in clinical development.

He serves as Vice President of Drug Discovery and Preclinical Development at Lysosomal Therapeutics Inc.  Dr. Skerlj is a Co-Founder and a Member of the Scientific Advisory Board of X4 Pharmaceuticals, Inc. He is also Co-Founder of Noliva Therapeutics.

MetaStat, Inc. (MTST), closed Wednesday's trading session at $0.16, up 14.29%, on 2,000 volume with 1 trade. The average volume for the last 60 days is 9,791 and the stock's 52-week low/high is $0.11/$1.40.

chart

Emblem Corp. (EMMBF)

TipRanks, Insider Financial, Micro Cap Research, 4-Traders, Marijuana Stocks, The Street, Penny Stock Tweets, Daily Marijuana Observer, CannabisNewsBreaks, Profit Confidential, Stockhouse, New Cannabis Ventures, Stockwatch, Proactive Investors, InvestorsHub, WalletInvestor, PotNetwork, and Cannabis Stock Picks reported on Emblem Corp. (EMMBF), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Emblem Corp., by way of its wholly-owned subsidiary, Emblem Cannabis Corporation, is a fully integrated LP (Licensed Producer) and distributor of medical cannabis and cannabis derivatives in Canada under the ACMPR (Access to Cannabis for Medical Purposes Regulations). The Company has three distinct verticals. These are cannabis production, patient education centers, and pharmaceutical dosage form development. Emblem is headquartered in Toronto, Ontario and lists on the OTC Markets.

The Company’s three businesses cover the full cannabis spectrum. This is from growing, to selling, to educating, to creating new forms of cannabinoid-based medication in standardized dosages.

Emblem has its Paris, Ontario facility. The new Paris facility was custom-designed and purpose-built specifically to cultivate and cure cannabis for medicinal use. This facility has a planned expansion to 17,000KG of annual production.

Emblem Cannabis is a team of passionate growers. Their dedication is to cultivating cannabis strains in their purest expression.

Furthermore, the Company has its Emblem Pharmaceutical. Mr. John Stewart, Chief Executive Officer of the Emblem Pharmaceutical Division, said, “…Emblem is identifying the cannabis strains with the greatest evidence of benefit in various conditions, cultivating those strains at medical grade and developing advanced dosage forms to provide patients with accurate, consistent, high quality and convenient to use cannabis formulations.”

Emblem also has its GrowWise Health division. GrowWise’s dedication is to providing patients and physicians with complimentary, personalized, education services to make informed decisions regarding medical cannabis treatment options.

Last month, Emblem announced that it signed a non-binding Letter of Intent (LOI) to acquire all of the issued and outstanding securities in Natura Naturals, Inc., which the Company does not already own, for $25 million in cash, $12.5 million in mortgage financing and 26,102,941 common shares of Emblem. Upon completion of the Transaction, Emblem will further its aggressive approach to sales growth domestically and globally backed by strong supply from the Natura greenhouse.

Natura Naturals (Leamington, Ontario) is a licensed cultivator of medical cannabis pursuant to Health Canada's ACMPR. Natura operates a 662,000 sq. ft. licensed greenhouse. It is now undergoing a phased conversion and retrofit, which is expected to bring up to 15,000 kg of annualized cannabis production online this year. Upon completion in 2019, the expectation is that the facility will bring total annualized cannabis production capacity to around 70,000 kg per year.

Last week, Emblem and GreenSpace Brands announced a strategic partnership to develop and commercialize cannabidiol (CBD) infused health and beauty products for the expected adult-use cannabis market. The pioneering partnership unites a highly-regarded Consumer Packaged Goods (CPG) company with one of Canada’s most trusted licensed producers of medical cannabis.

This partnership will take advantage of GreenSpace’s expertise in consumer brand development and distribution to launch products infused with Emblem’s CBD extracts across several verticals. Each approved product will indicate it is “Powered by Emblem” to signify Emblem’s involvement.

Emblem Corp. (EMMBF), closed Wednesday's trading session at $0.92, up 2.91%, on 131,115 volume with 121 trades. The average volume for the last 60 days is 187,184 and the stock's 52-week low/high is $0.82/$2.21.

chart

Enertopia Corp. (ENRT)

Penny Stock General, Shiznit Stocks, Cannabis Financial Network News, PennyStocks24, Fast Money Alerts, Stock Shock and Awe, Penny Champions, Equities.com, MassiveStockProfits, Wall Street Equities Research, Stockgoodies, GrowthPennyStocks, and Penny Dreamers reported earlier on Enertopia Corp. (ENRT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Enertopia Corp. is exploring a portfolio of three prospective lithium projects in the State of Nevada. Additionally, at the same time, the Company is working with water purification technology believed to be able to recover Lithium from brine solutions. Enertopia has its corporate office in Vancouver, British Columbia. The Company lists on the OTC Markets Group’s OTCQB.

Enertopia announced in April 2017 the formation of a Lithium business division for the exploration of Lithium. In May 2017, it closed the definitive agreement for the Lithium exploration project in Nevada.

In June 2017, Enertopia announced its Surface Exploration Program in Nevada. In Nevada, the Company has 2,560 acres of placer mining claims staked in Edwards, Smith and Big Smoky valleys.

The Central Nevada Lithium Brine Projects are proximal to an existing lithium mine. There is all weather access on paved roads and it is an ideal evaporation climate.

Genesis Water Technologies (GWT) is a partner of Enertopia. GWT is a manufacturer of advanced, innovative and sustainable treatment solutions for applications in process water, drinking water, water reuse and waste water for the energy, agriculture processing, industrial, municipal infrastructure, and building/hotel sectors.

Since September 2017, GWT has been evaluating data obtained from the first bench test results and other technical data provided by Enertopia to complete a larger and enhanced lithium recovery system. This $200,000 pre-paid second phase bench test is now complete. The second phase of the second bench test will use synthetic brine solutions, which will be created from the surface samples from the two bulk samples taken at Enertopia’s Clayton Valley project.

The next steps for the Company in 2018 are a bench test build out this month and preparation of synthetic brines in February. In March and April, bench testing of synthetic lithium brines will take place. In May will be final laboratory lithium recovery and Li2CO3 grade results.

Enertopia Corp. (ENRT), closed Wednesday's trading session at $0.02709, up 10.80%, on 51,000 volume with 8 trades. The average volume for the last 60 days is 132,196 and the stock's 52-week low/high is $0.015/$0.105.

chart

The QualityStocks Company Corner

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF)

The QualityStocks Daily Newsletter would like to spotlight FinCanna Capital Corp. (FNNZF).

FinCanna Capital Corp. (“FinCanna”) (CSE: CALI) (OTCQB: FNNZF) a royalty company for the U.S. licensed medical cannabis industry, announces that it has advanced US$ 1 million to its investee company ezGreen Compliance (“ezGreen”) which offers a state-of-the-art enterprise compliance and point-of-sale (POS) software solution for licensed medical cannabis dispensaries and cultivators.

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) is a royalty company aiming to be the capital partner of choice for high-growth, best-in-class businesses operating in the licensed U.S. medical cannabis industry. Primarily focused on the burgeoning California cannabis market, FinCanna leverages extensive investment expertise and industry experience to benefit its shareholders and portfolio companies.

Medical Cannabis Market

According to Ameri Research, the global market for licensed medical cannabis is growing at a compound annual growth rate (CAGR) of more than 21%, on track to exceed $63.5 billion by 2024. Within this market, FinCanna has identified considerable opportunity in California, the fifth largest economy in the world and the largest medical cannabis market in North America. Arcview Group forecasts California’s legal cannabis industry will grow at 21.1% CAGR to $6.5 billion in 2020, generating more than $1 billion in tax revenue.

Royalty Model & Portfolio

FinCanna’s “whole capital” solution for businesses in the licensed medical cannabis sector includes the provision of capital investment for a percentage of their future revenues. The FinCanna Capital Solution utilizes a royalty arrangement to deliver capital, in order to facilitate the growth or other specific objectives of its investees, and ensure the business opportunity is optimized. This model provides an alternative or complement to debt and equity financing, allowing investees to maintain financial flexibility and control of their business rather than entering into arrangements that may include restrictive debt structures or giving up an ownership stake.

FinCanna’s portfolio includes Cultivation Technologies, Inc. (“CTI”), a team of experts from Fortune 150 agriculture, medical cannabis, law, engineering and technology companies. FinCanna is providing funding to CTI for its planned, fully entitled, large-scale indoor medical cannabis facility to be developed in Coachella, California.

CTI has established an interim medical cannabis extraction facility (the “Interim Facility”) that will produce licensed medical cannabis products until the Coachella Project is complete. CTI is currently expanding its product line, Coachella Premium, to include vaporizer cartridges. Initial market feedback gathered during the product development phase indicates that Coachella Premium’s vaporizer cartridges offer a unique proposition within the vaporizer market, one of the fastest growing verticals in the cannabis market.

The Interim Facility can process up to 6,000 pounds of biomass per month, the equivalent of approximately 3.7 million grams of raw oil per year, with room for expansion. It is expected that the completed Coachella Project will be able to process 30,000 to 50,000 pounds of biomass per month, or the equivalent of 18 million grams to 30 million grams of raw oil per year.

Additionally FinCanna has entered into a royalty agreement with Green Compliance, a provider of point-of-sale software solution (“ezGreen”) for licensed medical cannabis dispensaries and cultivators. Green Compliance helps its customers comply with both the Health Insurance Portability and Accountability Act (“HIPAA”) and State Laws by ensuring patients’ confidential data is being handled properly, helping to protect from possible security breaches and financial and criminal liability resulting from potential violations.

FinCanna has also signed binding term sheet with Oakland, California-based Gram Co Holdings, subject to due diligence by FinCanna. Gram Co is a cannabinoid research and refinement facility focused providing B2B and B2C products and services to licensed medical dispensaries, infused product manufacturers, and numerous others in the cannabis supply chain. The company is also retrofitting a large, state-of-the-art medical cannabis extraction laboratory, which is expected to be operating in 2018.

The foregoing contains forward-looking statements regarding Cultivation Technologies Inc. (“CTI”) which are subject to risks, uncertainties and contingencies which include, but are not limited to the statements relating the future construction and completion of the CTI medical cannabis facility in Coachella, California, and the projected biomass processing and raw oil production at the facility. Such forward looking statements are based on assumptions regarding the construction, completion and operations of CTI’s proposed facility, including that CTI will obtain the financing required to build and equip its proposed facility, that CTI will obtain the additional financing required operate the facility, that construction facility is completed on time and budget, that CTI obtains state licenses to operate on a permanent basis, and that the equipment used in the cultivation of medical cannabis performs at scale in a similar way it performs at CTI’s pilot tests.

FinCanna Capital Corp. (FNNZF), closed the day's trading session at $0.21, up 14.13%, on 20,506 volume with 27 trades. The average volume for the last 60 days is 46,411 and the stock's 52-week low/high is $0.10/$0.8736.

Recent News

chart

DeepMarkit Inc. (TSX-V: MKT) (OTCQB: MKTDF)

The QualityStocks Daily Newsletter would like to spotlight DeepMarkit Inc. (MKTDF).

DeepMarkit (TSX-V: MKT) (OTCQB: MKTDF) employs an exciting marketing approach, known as gamification, through its marketing platform Gamify. To view the full press release, visit: http://nnw.fm/sE9jW. Also today, NetworkNewsWire released a report on the company detailing how DeepMarkit is taking this gamification market and turning web app visitors into loyal customers through its innovative and entertaining game design features. The company offers cutting edge solutions for e-commerce and was highlighted in a recent audio press release (http://nnw.fm/1p0KV).

DeepMarkit Inc. (TSX-V: MKT) (OTCQB: MKTDF), based in Calgary, Alberta, Canada, is a patent pending gamification technology company inventing new ways to engage consumers and other audiences. The Company’s proprietary promotions platform – “Gamify” – enables businesses and agencies to create branded games that incentivize consumers, thus driving sales, capturing data and generating leads. The DeepMarkit platform integrates next-gen gamification engagement mechanics with interactive advertising industry standards and powerful visuals, including 3-D images. Customers may choose from both free and paid solutions suitable for campaigns of all sizes, targeting multiple channels on the web, mobile and social media.

A team of seasoned, passionate gaming executives, led by president and CEO Darold Parken, has worked together for more than 15 years developing games and gaming systems that are still used today by some of the largest gaming companies in the world. This accomplished executive team founded Chartwell Technologies, acquired in 2011 by Amaya Gaming, which now is known as The Stars Group (Nasdaq: TSG) with a market cap of over $5 billion.

Gamify offers a selection of easily customizable gaming apps featuring a customer’s branded e-store in addition to tailored landing pages, technical support, real-time analytics, data collection and an engaging marketing campaign. Gamify’s patent-pending app comes complete with unique user incentives that draw consumers in with games and prizes, which in turn engages shoppers, turning them into buyers and building brand loyalty.

The gamification market is rapidly expanding and projected to be worth $22 billion by 2022, with a CAGR of 41 percent. DeepMarkit is the only publicly listed company focused solely on this exploding market that embraces any size of business, from the mom-and-pop shops to the blue-chip giants. DeepMarkit’s management team knows that increasing a customer’s conversion rate by a mere 1 percent has the potential to double revenue, which is why Gamify’s app and its ability to transform simple shoppers into engaged buyers is so compelling.

“Our marketing platform enables customers to build branded games that incentivize audiences, generate leads, and drive sales. Businesses need a way to stand out from the crowd,” Parken states in an investor’s video (https://www.youtube.com/watch?v=97hJoRKR92k). “DeepMarkit’s gamification platform gives customers that way to stand out and it’s a way that they can afford. That’s the strength of our platform. For a relatively small amount of money, any business can create a very powerful, high quality customer engagement using gamification.”

DeepMarkit recently entered into a joint marketing agreement with ITN International (“ITN”), a global leader in trade show data capture and analytics. The agreement will enable the 1.5 million exhibitors at the 125-plus yearly events serviced by ITN to purchase a customizable campaign with prize delivery and branded games that can be used in collaboration with ITN’s lead retrieval solutions. DeepMarkit and ITN are currently integrating DeepMarkit’s patent-pending gamification platform directly into ITN’s exhibitor portal.

“We started DeepMarkit because we have a passion for games and we believe in the power of games, not just for entertainment but more importantly as a tool for business,” Parken said. “DeepMarkit is a gamification company. What we mean by that is that we create innovative ways to use games for business purposes. Games to generate customer leads, games to promote products, deliver rewards, build brand awareness and customer loyalty.”

Selected as the winner of the New Company/Product pitch competition at the Retail Global 2017 Conference held in Las Vegas, Gamify’s platform has also attracted a $1.5 million investment from Allstate International LLC in Hong Kong. The investment gives Allstate a 10 percent stake in DeepMarkit and a great opportunity to bring the Gamify platform into the burgeoning Asian gaming market.

DeepMarkit Inc. (MKTDF), closed the day's trading session at $0.0249, up 5.06%, on 100,000 volume with 1 trade. The average volume for the last 60 days is 17,051 and the stock's 52-week low/high is $0.0237/$0.12.

Recent News

chart

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX)

The QualityStocks Daily Newsletter would like to spotlight Foresight Autonomous Holdings Ltd. (FRSX).

Self-driving cars are reliant on their sensors to see the world around them. After years of testing in favorable conditions, these cars are now being assessed in bad weather conditions. Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) has developed a sensor system that uses visible light and thermal imaging to see through fog, rain and snow, and has sold a prototype of the sensor to a leading global Chinese electric vehicle manufacturer.

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX), founded in 2015 and headquartered in Israel, is a technological innovator in automotive vision systems and driver assistance technology. Through its wholly owned subsidiary, Foresight Automotive Ltd., Foresight is engaged in the design, development and commercialization of stereo/quad-camera vision systems and V2X cellular-based solutions for the automotive industry based on 3D video analysis, advanced algorithms for image processing and sensor fusion. The company’s powerful and patented stereoscopic technology is derived from field-proven technology that has been deployed throughout the world for almost two decades.

Foresight’s innovative autonomous driving solutions are based on mature, proprietary stereoscopic image technology that uses two synchronized cameras to mimic human depth perception and produce a three-dimensional image. This 3D image can anticipate possible collisions with other vehicles, cyclists, pedestrians and other obstacles. The technology provides highly accurate real-time alerts about the vehicle’s surroundings while in motion. The systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts.

The company’s patents provide IP protection for its robust and proven proprietary stereoscopic technology, which was developed using the security technology of Foresight’s major shareholder, Magna B.S.P.

Foresight has developed three main products:

  • QuadSight™. This breakthrough detection system sets the bar for autonomous vehicle vision. It features nearly 100 percent obstacle detection with almost zero false alerts and operates optimally under all weather and lighting conditions, including darkness, rain, fog, haze and glare. QuadSight™ is the first quad-camera multi-spectral vision solution of its kind, driven by advanced and proven image processing algorithms. The system consists of two sets of stereoscopic infra-red and visible-light cameras that enable highly accurate and reliable obstacle detection for seamless 24/7 vision.
  • Eyes-On™. This solution uses advanced algorithms for accurate depth analysis and obstacle detection to provide a unique stereo vision Advanced Driver Assistance System (ADAS). It can detect all potential obstacles regardless of shape, form or material, including other vehicles, cyclists, pedestrians and animals. It has an accuracy and reliability of almost 100 percent and near zero false alerts.
  • Eye-Net™. This is a cellular-based accident prevention solution that is designed to provide real-time pre-collision alerts to vehicles and pedestrians. This proprietary system is deployed on smartphones and cloud-based servers operating on existing cellular networks, and it eliminates the need for additional designated hardware. Eye-Net™ is designed to provide a complementary layer of protection to advanced driver assistance systems and extends this protection to road users who are not in direct line of sight. It is optimally designed for both urban environments and high-speed scenarios to provide protection for the most vulnerable road users. On March 28, 2018, Foresight announced that it had completed a successful feasibility study of its Eye-Net™ accident prevention solution involving 120 users of Android and iOS cell phones located across Israel.

In 2017, Foresight sought more opportunities within the international market. The Company signed pilot agreements with three leading car manufacturers in China and completed pilot projects meeting all pre-defined requirements and criteria. In addition, FRSX completed a pilot project with Uniti Sweden.

Studies by the Insurance Institute for Highway Safety continue to emphasize the dramatic reduction in accidents and injury-related crashes reported when vehicles are equipped with collision avoidance systems. A recent study by the Institute states that the rate of single-vehicle, sideswipe and head-on crashes was 11 percent lower in vehicles with the warning systems. More importantly, the study shows collision avoidance technology cut the rates of injury crashes of the same type by 21 percent.

Foresight Autonomous Holdings, Inc. also holds a 32 percent interest in RailVision, a company that develops advanced systems for railway safety and maintenance. RailVision has successfully completed 13 tests in Israel, Germany, Italy and Switzerland in addition to a real-time system test with a European railway operator. Over the course of 2017, RailVision successfully completed rounds of financing totaling $5.8 million and started the process of licensing the system according to European standards.

Haim Siboni is the founder of Foresight and has served as the company’s chief executive officer and director since 2015. Siboni, a passionate entrepreneur, has an extensive background in the marketing and business management sectors in the fields of electronics, video, TV, multimedia, computerized systems, line and wireless telecommunication, design and development of systems and devices, including electro-optic radar systems. He is the founder and CEO of Magna B.S.P., Foresight’s major shareholder and a leading innovator in the field of homeland security surveillance solutions.

Foresight Autonomous Holdings Ltd. (FRSX), closed the day's trading session at $2.9899, off by 0.34%, on 12,750 volume with 35 trades. The average volume for the last 60 days is 56,602 and the stock's 52-week low/high is $2.44/$8.20.

Recent News

chart

NUGL Inc. (OTC: NUGL)

The QualityStocks Daily Newsletter would like to spotlight NUGL Inc. (NUGL).

NUGL Inc. (OTC: NUGL) this morning posted an update regarding its marketing strategy, specifically, the expansion of its cannabis platform to the entire north american market. To view the full press release, visit: http://cnw.fm/Fhu6g.

NUGL Inc. (OTC: NUGL) is focused on leading the evolution in business relations, development and organic data in the cannabis industry with a distinct platform. In this effort, it has developed a leading-edge, first of its kind search app and online directory for the marijuana industry that provides a one-stop source and listings for dispensaries, strains, doctors, lawyers, service professionals, vape shops, hydro stores and brands.

Headquartered in Chino Hills, California, which is home to a projected $5 billion legal marijuana marketplace, NUGL is on track to become a major asset for the global cannabis industry and related services sectors. The company recently established a strategic partnership with Thinklogic and appointed CEO Chris Adams to NUGL’s growing board of directors. Thinklogic is a top-level software development company specializing in projects for start-ups to Fortune 500 companies.

“This strategic partnership puts NUGL in a distinguished class, adding a first-rate technical software expert like Chris gives NUGL a unique technological advantage,” said Brandon Vargas CEO of NUGL. “With the addition of Chris’s knowledge and expertise combined with Thinklogics’ experienced and skilled staff, NUGL will have the ability to evolve and build a strong infrastructure unmatched in the 420 industry.”

NUGL is nearing completion of its initial launch timeline, with plans to launch the app on both Android and iOS platforms within the next few weeks. NUGL’s live testing of its software includes enhanced reviews that detail up to 10 category ratings. Each of the category rankings allow users to leave comments and choose among a 5-star rating among all categories or as few as they wish. The software’s rating platform allows for customization and transparency for users while providing invaluable feedback to shops and professional services.

“This is a major feature that is critical to our community,” said Jeff Odle, NUGL’s CTO. “Enhanced ratings will be a definitive difference validating our organic listings and raising the standard for the industry. We want the users to know what they are getting before they step into a store or sign up for a service.”

Leadership Team

NUGL is growing its team of developers and launching new features on an ongoing basis. The company is ahead of an impressive timeline, which includes building blocks for scalability and massive growth.

“Everything we do is focused on user experience. Our philosophy is simple – make it fun and easy to use, with the purest and most unbiased results,” said Ryan Bartlette, NUGL CMO. “As the industry evolves and becomes more sophisticated, NUGL will adapt and build the best marketing technology for the cannabis-related companies. We have gotten in on the ground level and know the pulse of the industry.”

NUGL CEO Brandon Vargas is a founding member of G6 Management, a full-service consulting firm advising cannabis professionals in all aspects of business. With over 10 years’ experience in the cannabis space, he has worked on dispensary, cultivation and infusion entity formation, licensing, real estate acquisitions, construction and build out, marketing, policy and procedures, compliance, staffing, and capital raises. Vargas has an extensive background working with various medical marijuana companies on investment and in developing greenhouse and commercial cultivation, distillate for vapes cartridges, CBD oils and infusions.

CMO Ryan Bartlette is co-founder and CMO of 23Forty LLC and Boxy. He has expertly positioned and branded many companies while bringing them to market and is a sought out graphic artist, front-end developer, photographer, and visual artist with experience in the entertainment and technology industry.

Jeff Odle, NUGL CTO, is a successful senior software architect has a long and distinguished career developing some of the most innovative, cutting-edge platforms available. His unique and distinctive approach to creating the blueprint for advanced programming is industry leading and unprecedented. He is a top-level architect responsible for developing some of the most forward-­looking software for various industries.

NUGL’s board of directors includes John R. Armstrong, a founding partner of Horwitz + Armstrong, a full service general business firm handling all aspects of litigation and business strategy and advice. Armstrong and his partner, Lawrence Hortwitz, have more than 10 years of experience in the cannabis space, representing cannabis professionals in all aspects of business including business formation, licensing, compliance with local and state regulations, real estate acquisitions, corporate mergers and acquisitions, financing, inclusive of capital raises and alternative financing, contracts, and all forms of dispute resolution.

Board member Hendrik Klein, founder of Da Vinci Asset Management, a privately-owned investment firm, serves as CEO and executive board member of Fritz Nols AG, a capital marketing consulting firm specializing in trading and asset management. Klein has received several industry awards including the Austrian Hedge Fund Award, the German Hedge Fund Award, and most recently was named the Global Best Performing Systematic Quantitative CTA. Klein and the Da Vinci team employ the latest quantitative data research and analysis in their innovative investment strategy.

NUGL Inc. (NUGL), closed the day's trading session at $1.41, up 1.44%, on 81,517 volume with 85 trades. The average volume for the last 60 days is 121,340 and the stock's 52-week low/high is $0.405/$1.80.

Recent News

chart

BLOCKStrain Technology Corp. (TSX-V: DNAX)

The QualityStocks Daily Newsletter would like to spotlight BLOCKStrain Technology Corp. (DNAX).

Canada’s inexorable march toward full legalization of cannabis for the adult user in both the medical and recreational markets is much anticipated by the public and Vancouver, Canada-based BLOCKStrain Technology Corp. (TSX.V: DNAX). Major features of BLOCKStrain’s proprietary, end-to-end cannabis tracking platform are rapidly being finalized by the company’s development team, Chief Technology Officer Tommy Stephenson said in a news release (http://cnw.fm/jRO72).

BLOCKStrain Technology Corp. (TSX-V: DNAX), a full-service software company headquartered in Vancouver, BC, Canada, has developed the first integrated blockchain platform that registers and tracks cannabis intellectual property (“IP”) from genome to sale. It is proprietary, immutable and cryptographically secure, thereby establishing a single source of truth for cannabis strains and their ownership.

With Canada set to legalize marijuana use for recreational purposes, and other jurisdictions following suit around the world, new challenges will emerge regarding the ability to provide a safe and legal inventory of a product that up until now was largely only available on the black market. Cannabis will be heavily tested and regulated by numerous regulatory bodies in Canada. The cannabis industry faces unique challenges that BLOCKStrain specifically helps it address, including:

  • Mandatory Testing: Through BLOCKStrain’s platform and lab-testing partners, the process is more efficient and streamlined, cutting the administrative burden in half and getting products to market faster;
  • DNA Based Product Validation: The underlying blockchain technology creates a genetic fingerprint that identifies and validates the product electronically so any participant on the platform, including consumers, can view and track what’s happening with that product from genome to sale;
  • Intellectual Property: Third, and perhaps most importantly, the BLOCKStrain platform protects the intellectual property of growers and breeders. This is important for the industry’s growth as products evolve and develop. If a craft grower, for example, creates a popular strain with unique characteristics, it will be able to protect its intellectual property by simply registering the strain’s genome with BLOCKStrain and locking that data into the blockchain. It will reside there forever and will be readily accessible in the event of future disputes, bringing a level of trust to the industry and ensuring licensing fees are paid to all players in the market.

VERIFICATION = CERTIFICATION

BLOCKStrain’s genetics verification process is authentic and incredibly effective. User groups register by creating an account with BLOCKStrain, which starts the process. Organizations and independent growers submit seeds, flower and post-extraction product for testing to a registered and approved testing facility, which then submits test results to BLOCKStrain. Pre-existing data of genetic cannabis strains can also be submitted via BLOCKStrain verification administrators, with those results being added to the user group’s blockchain account. Submissions are entered into BLOCKStrain, and the transaction is completed and recorded.

Each time an item is tested and verified by the network, a Registration Affidavit is auto-generated and given a unique “BLOCKStrain Address” along with a traceable QR Code. Producers, patients and consumers are able to not only verify the test but can also rate the product, write reviews and share opinions. This detail is stored within BLOCKStrain and, just like the test results, cannot be tampered with or modified. Verification and certification are earned by all parties for their participation.

SAFE CONSUMER SUPPLY

BLOCKStrain demystifies the seed-to-sale process for all relevant stakeholders including producers, distributors, shippers, government agencies and consumers by creating a repository of cannabis genomes on an immutable, shared ledger. Thousands of cannabis strains exist and cultivators are breeding new strains all the time. The proliferation of cannabis strains can prove problematic for consumers since there are more than 500 known chemical compounds in a single plant. Furthermore, since several dozens of these compounds have been identified as pharmacologically active, it becomes more and more difficult for consumers to know what they are purchasing.

It is for this reason that being able to quantify the genetics, potency and equivalencies among cannabis products is crucial to the future of legalized cannabis. The difference is not so much in the name or brand attached to the cannabis, but the DNA of the plant itself. BLOCKStrain ensures product integrity, safety, regulatory compliance, product licensing and authenticity – all vital elements for the emerging cannabis industry.  This technology also bolsters the process of meeting government regulatory standards by providing real-time visibility of industry operations to agencies assigned to enforce and regulate cannabis activity.

INTELLECTUAL PROPERTY RIGHTS

BLOCKStrain allows for the defense of intellectual property rights for the grower with an authentic, verifiable chain of evidence embedded in the blockchain itself. Proof of ownership for a specific strain of cannabis is paramount in a multibillion dollar industry. Real life ownership disputes have already begun in the industry with legal battles underway. Unfortunately, the framework for resolving these disputes has yet to be defined and they are not likely to be resolved anytime soon.

Consumers and regulators alike want to know whether a cannabis product grown and sold at a local dispensary is safe and meets quality control standards. BLOCKStrain enhances trust of origin from genome-to-sale as cannabis flows through the supply chain, verifying critical steps in the process such as who is growing the plant, which seed is planted and where did it come from, whether pesticides were used, how much was grown, which tests are used to establish quality and potency, where the product is transported and how, and whether possession limits are meeting regulatory standards.

In summary, BLOCKStrain has developed the most comprehensive, secure and community-driven cannabis genetics archival platform for cannabis breeders and growers, large and small, to protect and release their varieties into the public domain, all while compensating and rewarding them for their contributions.

BLOCKStrain Technology Corp. (DNAX), closed the day's trading session at $0.195, up 8.33%, on 85,200 volume. The stock's 52-week low/high is $0.1049/$1.20.

Recent News

chart

Zenergy Brands, Inc. (OTC: ZNGY)

The QualityStocks Daily Newsletter would like to spotlight Zenergy Brands, Inc. (ZNGY).

Next-generation energy and technology company Zenergy Brands (OTC: ZNGY) is well-positioned in a growing market as concerns over climate change and efforts to conserve energy continue to grow. To view the full press release, visit: http://nnw.fm/UK3xr.

Zenergy Brands, Inc. (OTC: ZNGY) is the nation’s leading next-generation energy and technology company operating in the emerging smart energy, conservation, and utility industries. Headquartered in Texas, Zenergy provides an entire suite of conservation-based products and services that enable clients to achieve sustainability goals, reduce carbon emissions and improve their bottom line. The company’s cutting-edge Zero Cost Program™ reduces utility expenses by 20 percent to 60 percent by offering energy conservation, smart controls, and efficiency-based products and services to residential, commercial, industrial and municipal end-use customers.

The Zero Cost Program™ is a financing mechanism that allows customers to reduce water, natural gas and electricity expenses by implementing proven conservation technologies at no out-of-pocket cost. The Zero Cost Program™ enriches businesses by immediately reducing energy consumption through the use of smart controls, building automation, LED lighting solutions, refrigeration optimization, efficient water systems, EC motor controls, demand-side management and load factor correction.

A unique Managed Energy Services Agreement (“MESA”) allows a portion of these utility savings to be retained by Zenergy’s partner financing the upgraded, retrofit equipment and installation costs until a specified repayment period ends. After that, clients reap all the financial rewards of the technologies implemented, which Zenergy estimates should range between 25 percent and 45 percent of total utility costs.

Residential customers seeking cost-effective energy savings can also choose from a suite of “Smart Home” products including home automation, security monitoring, and energy conservation services that can be controlled 24/7 from the comfort and convenience of their smartphones or internet-connected smart devices. Zenergy’s residential program offers partnership opportunities for homebuilders and residential, multi-family real estate developers to provide smart home technologies to high-end customers.

Zenergy Brands’ acquisition of Enertrade Electric LLC, a fully operating, licensed Texas-based Retail Electric Provider (REP), further increases the company’s value proposition. Zenergy CEO Alex Rodriguez said this new subsidiary adds an essential complementary service to the company’s suite of smart energy products and services.

“Since our founding, our vision has been to converge smart controls (home and building automation) with energy conservation and retail energy to deliver the comprehensive smart energy service to customers,” Rodriguez said.

On a global scale, residential and commercial buildings account for nearly 45 percent of the world’s total energy consumption. Improving the energy efficiency of these homes and buildings is often a more affordable way to reduce harmful gas emissions while minimizing the need for new energy production. According to Navigant Research, global revenue for energy-efficient commercial building retrofits alone is expected to grow from $71.4 billion in 2016 to $100.8 billion in 2025. At the same time, the energy-efficient devices market is expected to reach a market size of $908 billion by 2022. Increasing demands for reduction in energy consumption and greenhouse gas emissions along with concerns over climate change are contributing factors driving the market’s overall growth.

Zenergy Brands, Inc. (ZNGY), closed the day's trading session at $0.0007, even for the day, on 7,666,788 volume with 14 trades. The average volume for the last 60 days is 21,268,418 and the stock's 52-week low/high is $0.0005/$0.03.

Recent News

chart

Net Element (NASDAQ: NETE)

The QualityStocks Daily Newsletter would like to spotlight Net Element (NETE).

Net Element, Inc. (NASDAQ: NETE) expects a recent acquisition, purchased through subsidiary Unified Payments, to generate well over $5 million in gross profits over the next four years, with recurring profits expected to continue to enhance the company’s profit margins, the company stated in a news release (http://nnw.fm/5M3h7).

Net Element (NETE), is a global financial technology and value-added solutions group that supports electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce, and mobile devices. Net Element operates a payments-as-a-service transactional model and value-added services platform for small to medium enterprises in the U.S. and selected emerging markets. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest growing companies in North America on Deloitte’s 2017 Technology Fast 500 ™ and South Florida Business Journal’s 2016 fastest growing technology companies.

Net Element believes the future of global commerce is being revolutionized as consumers quickly migrate toward omni-channel shopping utilizing mobile devices, desktop, and online services. Net Element’s all-in-one payment solutions support and unify a whole range of applications through a single, robust platform, allowing global onboarding and support for multiple payment methods.

Net Element has also launched a new blockchain-focused business unit that will develop and deploy blockchain technology-based solutions. Net Element expects the new division to create a decentralized crypto-based ecosystem that will act as a framework for an unlimited number of value-added services, connecting merchants and consumers in a seamless, economically efficient transaction. This new business unit intends to also identify and invest in unique projects that decentralize and disrupt the payment processing industry by combining blockchain technology and real-world applications with talented development teams, strong fundamentals and addressable markets large in size.

“We believe that we’re at the dawn of a new evolution where additional digital payment methods are being introduced,” Net Element CEO Oleg Firer, says. “Introduction of our division focused on blockchain as part of the NASDAQ-listed entity will add transparency and compliance assurance to our investors as well as provide access to deploy value-added services to over 20 million electronic commerce clients that are currently part of Net Element’s growing network.”

Net Element clients are treated to customized solutions that provide the flexibility needed to keep up with customers. Among the services offered are mobile payment apps that accept payments anywhere, anytime; cloud-based solutions built to increase productivity and enhance revenue for clients and partners; marketing solutions that turn lookers into buyers; and business analytics that make it easy for clients to monitor business metrics, engage with customers and compare the competition. Its multi-channel platform combines e-commerce, offline, point-of-sale, comprehensive back office tools, mobile point-of-sale, credit scoring and customer interaction in one powerful platform-as-a-service technology.

Net Element owns and operates a global mobile payments and transactional processing provider, TOT Group, Inc., with the following subsidiaries:

  • Unified Payments – An award-winning, customized mobile billing and payments solution, recognized by Inc. Magazine as the No. 1 Fastest Growing Company in America in 2012.
  • Digital Provider – A leading provider of SMS messaging and mobile billing solutions.
  • Aptito – A next-generation, all-in-one, cloud-based restaurant management and point-of-sale payments platform using wireless technology.
  • Payonline – A fully integrated, processor agnostic electronic commerce platform.

Net Element is ranked No. 418 on Deloitte’s 2017 Technology Fast 500™ list of North America’s 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies. Net Element grew 190 percent. The company’s chief executive officer, Oleg Firer, credits the company’s progression to organic growth in its North America Transactions Segment, specifically the success of its Unified Payments brand, which focuses on value-added payment acceptance solutions for small to medium enterprises in the United States.

“The Deloitte 2017 North America Technology Fast 500 winners underscore the impact of technological innovation and world class customer service in driving growth, in a fiercely competitive environment,” said Sandra Shirai, vice chairman, Deloitte Consulting LLP and U.S. technology, media and telecommunications leader. “These companies are on the cutting edge, and are transforming the way we do business.”

Net Element’s suite of application performing interfaces (APIs) and connectors power commerce for businesses of all sizes through multi-channel platforms, all-in-one digital solutions, and end-to-end encryption of cardholder data utilizing tamper resistant hardware that ensures integrity and simplifies security.

Net Element’s corporate team is led by director and CEO Oleg Firer, who is responsible for the overall vision, strategy and execution of the company’s mission of powering global commerce. He is joined by CFO Jeffrey Ginsburg, CPA, and Steven Wolberg, who is the company’s chief legal officer and secretary. Each corporate officer brings a unique blend of leadership, vision, experience and creative energy to the company.

From mobile payments and value-added transactional innovations such as Digital Provider and Aptito to e-commerce and retail payment transaction processing brands like Payonline and United Payments, Net Element is transforming the online and mobile experience.

Net Element (NETE), closed the day's trading session at $6.94, off by 0.50%, on 15,180 volume with 110 trades. The average volume for the last 60 days is 126,752 and the stock's 52-week low/high is $2.556/$33.51.

Recent News

chart

Pivot Pharmaceuticals Inc. (OTCQB: PVOTF)

The QualityStocks Daily Newsletter would like to spotlight Pivot Pharmaceuticals Inc. (PVOTF).

Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased to announce that its wholly-owned subsidiary, Pivot Naturals LLC, has entered into a Binding Letter of Intent with Healthcare Options for Patients Enterprises LLC, dba HOPE Cannabis Products ("HOPE"). Based in Las Vegas, Nevada, HOPE is a fully licensed extractor, manufacturer and distributor of cannabis products including effect-based vape cartridges, syringes, micro-dosed oral sprays, pre-rolls, infused pre-rolls, infused cold brew coffee and infused lemonade. Also today, CannabisNewsWire released a report on the company detailing how PVOTF recently announced its entrance into a definitive agreement with SoluBest Ltd. to acquire the worldwide rights for the use, development and commercialization of its patented Solumer™ Oral Drug Delivery Technology. To view the full press release, visit: http://cnw.fm/z7tGu.

Pivot Pharmaceuticals Inc. (OTCQB: PVOTF), based in Vancouver, Canada, is an emerging biopharmaceutical company engaged in the development and commercialization of pharmaceuticals and nutraceuticals that provide novel treatments for unmet healthcare needs. Pivot’s recent acquisition of BiPhasix ™ Transdermal Drug Delivery technology for the delivery of cannabinoids (CBD) to patients provides the answer for an age-old problem associated with cannabinoid-based therapies: the lack of a robust smoke-less delivery mechanism.

Research into the bioavailability of cannabinoid-based therapeutics shows that rates of absorption vary greatly between smoking cannabis to an orally-consumed product, with a difference noted even between individuals. Cannabinoids are degraded in the stomach and smoking may not appeal to patients for health or lifestyle reasons. Topical delivery, while a better alternative, has suffered from weak formulation issues. Transdermal cannabinoid delivery, on the other hand, could provide a better alternative route since it reduces side effects and bypasses other absorption issues. In addition, transdermal delivery provides the benefit of enabling patients to access a steady stream of medication over a prolonged period with fewer side effects.

Pivot Pharmaceutical’s newly created subsidiary, Pivot Green Stream Health Solutions Inc. (“Pivot Green Stream”), will focus on improving the bioavailability of cannabinoid-based and pharmaceuticals. BiPhasix™ has been tested in FDA and EMA approved human clinical trials, which have shown the delivery system enhances the bioavailability of many drugs and improves clinical outcomes. Pivot Green Stream is tasked with developing several natural health products containing cannabinoids (CBD) that can receive a Health Canada Natural Health Product (NHP) designation. This marketing method ensures a shorter development cycle and faster revenue generation opportunities.

Pivot Pharmaceuticals Inc., which has positioned itself as a growing and crucial vertical in the cannabis industry, represents a compelling opportunity in the biotechnology field. The company’s plans include working with Licensed Producers (LP) and Licensed Dealers (LD) to bring newer therapies to patients. The company has also applied to list on the Canadian Stock Exchange (CSE).

The global medical marijuana market is expected to reach a value of $55.8 billion by 2025, according to a new report by Grand View Research, Inc. The growing number of states and countries gaining approval for using cannabis in therapeutic applications is expected to continue driving the market forward.

Pivot Pharmaceuticals has assembled a highly experienced management team, bringing together a wealth of clinical, commercial, product development and financial experience. Among the many healthcare targets in Pivot’s pipeline are cancer supportive care, pain and inflammation, women’s sexual dysfunction, dermatology and eye disease.

Pivot Pharmaceuticals Inc. (PVOTF), closed the day's trading session at $0.4022, off by 2.46%, on 31,280 volume with 22 trades. The average volume for the last 60 days is 105,387 and the stock's 52-week low/high is $0.047/$2.46.

Recent News

chart

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H)

The QualityStocks Daily Newsletter would like to spotlight PreveCeutical Medical Inc. (PRVCF).

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces the first product development program of the Company's newly created medicinal cannabis division is focusing on the development of cannabinoids as a preventive treatment for anxiety disorders using PreveCeutical's nasal delivery, sustained release, Sol-gel ("Sol-gel") delivery platform. For further information on the Company's new medicinal cannabis division, see news release dated July 24, 2018.

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H), headquartered in Vancouver, British Columbia, Canada, is a health sciences company dedicated to researching and developing innovative options for preventive and curative therapies utilizing organic and Nature Identical™ products. The company is strategically staking out select positions in the medically acute areas of diabetes and obesity, pain management, neurological disorders and cancer.

PreveCeutical Medical Inc. had its beginnings in 2009 when Stephen Van Deventer, a seasoned businessman and venture capitalist, and Kimberly Van Deventer, a successful entrepreneur, met and formed a business partnership. The duo created Cornerstone Global Partners, a venture capital and business development company, and became involved in numerous ventures including building companies such as Aurora Cannabis Inc. Taking their interest in the health and wellness market further, the pair began researching how nature and science can work together to benefit health-conscious consumers. Coining and trademarking the word “PreveCeutical” – a combination of the words “preventive” and “pharmaceutical” – was a precursor to the company’s formation and incorporation in October 2015.

The company’s first product was developed in the Dominican Republic and is now marketed and distributed worldwide by PreveCeutical. It is a Caribbean Blue Scorpion venom product sold under the trade name CELLB9®. This product is an oral dilute solution infused with select peptides sourced exclusively from the blue scorpion (Rhopalurus princeps) found only in Caribbean nations. The active potentiated ingredients in CELLB9, which have been used in over 40 countries for over a decade, appear to support health at a deep, cellular level. PreveCeutical’s research team is using proprietary chemistry to generate Nature Identical™ peptides derived from natural compounds found in Caribbean Blue Scorpion venom with the goal of eventually treating, regulating and preventing cancer progression. Peptides are also being used to target an array of disease indications including metabolic disorders, pain management, cancers, cardiovascular and infectious diseases.

PreveCeutical is developing the first nose-to-brain delivery system of cannabinoids (CBDs) with a novel process that prepares insoluble drug-containing nano-micelles and successfully incorporating them into a proprietary sol-gels application, essentially creating a targeted drug delivery vehicle. Intended for use via a nasal spray, this unique formulation rapidly gels upon contact with mucosal tissue, which paves the way for direct nose-to-brain delivery. This novel application eliminates first pass metabolism (stomach, intestines, liver), potentially improving bioavailability and delivering extended time release formulations that may alleviate side effects of higher dosage therapeutics. This CBD-based patented formula is projected to be deployed in selected markets with licensed medical marijuana companies within 18 months.

PreveCeutical is working with four leading Australian research centers to develop a curative therapy for diabetes and obesity. This four-year program involves engineering a novel approach that selectively targets the gene that encodes for the protein PTP-1B, which is implicated and over-expressed in both type-2 diabetes and obesity. PreveCeutical’s gene-silencing technology would effectively “turn off” the genetic signal which leads to the over-production of this key protein molecule, bringing it back down to safe, normalized levels, and prevent the body from storing excessive fat. Diabetes kills one person every six seconds, with more than $800 billion spent globally on the disease.

Another exciting joint venture, established with Sports 1 Marketing, will focus on the therapeutic potential in the peptides and proteins connected to the Caribbean Blue Scorpion venom to potentially treat mild brain injury concussions. Developing a therapeutic product geared towards athletes who suffer from concussions could help alleviate suffering experienced by those who are affected by head trauma.

PreveCeutical Medical’s science and research team is led by Dr. Harendra (Harry) Parekh, Ph.D., who is based at the University of Queensland’s (UQ) Pharmacy Australia Centre of Excellence (PACE), and Dr. Makarand Jawadekar, Ph.D., whose 28 years of R&D experience with Pfizer Inc., is applicable in his role as chief science officer. Research collaborators include Dr. Rakesh Veedu, an emerging expert internationally in the field of molecular medicine, and Professor Grant Ramm, who is currently head of a leading medical research institute located in Brisbane, Australia.

PreveCeutical Medical is partnering with leading industry experts and companies in its quest to be a leader in the preventive health sciences sector. Its Research and Development partnership with UniQuest, the main commercialization company for the University of Queensland, provides PreveCeutical with the rights to all intellectual property arising from projects created under the agreement. PreveCeutical Medical Inc.’s management team brings an extensive portfolio of research experience, product development, deep corporate strategy and capital markets leadership to the company’s core.

PreveCeutical Medical Inc. (PRVCF), closed the day's trading session at $0.031, off by 8.82%, on 44,550 volume with 24 trades. The average volume for the last 60 days is 601,272 and the stock's 52-week low/high is $0.002/$0.20.

Recent News

chart

Auscrete Corp. (OTC: ASCK)

The QualityStocks Daily Newsletter would like to spotlight Auscrete Corp. (ASCK).

NetworkNewsAudio (NNA), a NetworkNewsWire (NNW) solution that delivers clients unparalleled visibility, recognition and brand awareness in the investment community, today announces the online availability of its interview with Auscrete Corporation (OTC: ASCK), a client of NNW engaged in the construction of “green” housing and commercial structures built from their lightweight hybrid concrete/insulation wall and roof panels. The interview can be heard at http://nnw.fm/MBZ7b.

Auscrete Corp. (OTC: ASCK) is a building products manufacturer of environmentally-friendly, energy-efficient housing and commercial structures using a lightweight hybrid concrete material developed through a proprietary technology. Auscrete’s unique process produces a medium that is cost-efficient, extremely soundproof, offers high insulation values, requires very low maintenance, won’t burn, non-toxic, highly resistant to insects and mold, and resists damage from hurricane forces and earth tremors. It’s a more affordable, energy-efficient “green” construction material that can be utilized for building residential housing and commercial structures.

Affordable homes are increasingly becoming more difficult to purchase in the U.S. with the median price of a new home consistently rising while wages stay stagnant in many areas and mortgage rates rise. The average price of new homes sold in the U.S. in 2017 was nearly $385,000, according to Statista. The homeownership rate in the U.S. has been in decline since 2004, the report states, and now amounts to a little more than 64 percent of Americans.

Auscrete’s lightweight concrete product is described as an aerated concrete material following infusion of a specially designed foaming agent during manufacture. This technology enables the product to have millions of minuscule air bubble “aggregates” introduced and evenly distributed throughout the cast sections, which creates a unique, lightweight product without compromising strength or structural integrity. Each hybrid panel also incorporates a distinctive XPS insulation amalgamation that guarantees greater comfort in a wide range of climatic conditions and a reduction in heating and cooling costs. The final product is a light and strong concrete panel with an extremely high insulation value, as well as excellent fire resistance and sound-proofing qualities.

Auscrete’s product also offers a high strength-to-weight ratio, allowing architects and engineers to develop new design and construction concepts that take advantage of the product’s reduced weight, which is nearly half that of normal concrete. Each panel can be cast in large sections, a common size being 16-feet by 8-feet, for easier transportation and faster construction on site. Savings are enhanced, not only by the energy efficiency of each panel, but through the use of mass production techniques. Auscrete estimates the company can produce a ready-to-move-in turnkey house for around $100 per square foot, which is significantly less than the 2017 median list price of $148 per square foot in the U.S., according to a report by Zillow.

Auscrete is constructing its flagship, 10-acre facility in Goldendale, Washington, on initially 5 acres the company recently purchased with the option to purchase another 5 adjacent acres. This new campus will ultimately comprise of 6 buildings, including 3 production buildings of 25,000 sq. ft. with each production buildings’ capacity of 100 homes annually, giving this flagship facility the ability to produce 300 homes or equivalent commercial structures per year.

During this construction phase, Auscrete has leased a commercial building in Goldendale. The facility will be used as a temporary headquarters and will also serve as a refurbishing station for production equipment the company has developed and used in its prior production plant. John Sprovieri, CEO and founder of Auscrete Corporation, is at the helm of the company with Mike Young serving as vice president of internal operations and Otto Paulette controlling the in-house mechanical services.

Auscrete’s Investor Relations Director, Lee Odom said, “The company’s construction process has already attracted interest from many developers, contractors and builders, some with large tracts of land looking to make available, significant numbers of Affordable Homes throughout the Country. Additionally, there have been significant commercial projects offered including 300 room destination hotel resorts, correctional facilities, a shopping complex, and a court house along with a flood of inquiries from people who are looking for more affordable building options”.

“This could really launch the commercial aspect for?ASCK, apart from residential home production which so many investors are not yet aware of,” Odom said. “A strong combination of both will lead?ASCK?to better performance through all business cycles, thus continuing to enhance the shareholder values, which is always the ultimate goal of Auscrete Corporation.”

Auscrete Corp. (ASCK), closed the day's trading session at $0.0599, off by 15.87%, on 133,100 volume with 12 trades. The average volume for the last 60 days is 121,800,861 and the stock's 52-week low/high is $0.0001/$0.10.

Recent News

chart

GTX Corp (OTC: GTXO)

The QualityStocks Daily Newsletter would like to spotlight GTX Corp (GTXO).

GTX Corp (OTCBB: GTXO), a pioneer in the field of wearable GPS human and asset tracking systems and wandering assistive technology, today announced that George Mason University’s College of Health and Human Services has received a grant from the Alzheimer's & Related Diseases Research Award Fundto continue its machine learning wandering prediction research.

GTX Corp (OTC: GTXO), a For Profit For Purpose company, designs, manufactures and commercializes various products and services in the GPS tracking and monitoring business.  Operating domestically and internationally, via two subsidiaries engaged in the internet of things (IoT) and wearable technology industry. Founded in 2002 and headquartered in Los Angeles, California, the company is a pioneer in Smart GPS, cellular and Bluetooth Low Energy (BLE) tracking technology, offering complete, end-to-end tracking solutions through a proprietary IoT enterprise monitoring platform – the IoT Machine to Machine platform – backed by state-of-the-art hardware, software and connectivity solutions, patents and software algorithms.

Operating under the motto “We Put the ‘Where’ in Wearable Tech,” GTX’s main goal is to keep its customers connected to who and what matters most, with each of its patented tracking technologies providing real-time location coordinates on a map via a personalized portal. The company prides itself on offering not only technologies, but also effective solutions that provide safety, security and peace of mind by helping customers locate their loved ones or lost valuable items.

With a portfolio that includes more than 80 patents filed and issued and with products and services available in 35 countries, GTX’s tracking solutions use the latest in miniaturized, low-power GPS, mobile, RF and BLE technology, that can integrate seamlessly with multiple consumer products, enterprise and military applications. The company became a U.S. Military contractor in 2017 and is already developing asset and human tracking technology for the U.S. Air Force. Its list of customers also includes public health authorities and municipalities, emergency and law enforcement, NGOs, private companies, public and private senior care homes, and consumers.

The company’s flagship product is the award-winning GPS SmartSole®, the world’s first invisible wearable tracking device created specifically for people at risk of wandering, becoming lost or disoriented, including patients with Alzheimer’s, autism, dementia, traumatic brain injury and other cognitive problems. According to the World Alzheimer Report 2013 (http://nnw.fm/mrcV2), there are more than 100 million people worldwide who need constant care and monitoring because of a cognitive disorder, and their number is expected to rise to 277 million by 2050. Due to its hidden location – inside a shoe insert, the device can also be used by people undercover or at risk of kidnapping, such as government agents, military personnel, law enforcement, journalists, corporate executives, etc.

Other tracking devices designed and commercialized by the company for civilian or military use include:

  • Take-Along Tracker 3G: A powerful mini-tracking device with GPS, 2G and 3G GSM data and voice capabilities, as well as a motion sensor and sleep mode. The device can be easily attached to a keychain, lanyard, dog collar, pocket, bag or plush toy for a discreet but advanced tracking solution.
  • Invisabelt: Designed for children, this slim GPS tracker hidden inside a small waistband belt has a battery life of up to two days and is a great solution for parents who want to monitor their children’s location at all times.
  • Track My Workforce: An easy and cost-effective solution that allows businesses to track and monitor their mobile workforce. The app is available for both Android and iOS systems, and allows employers to monitor their workforce from a single company account.
  • P.E.T.S. -Personnel Equipment Tracking System: Currently in use at the Edwards Air Force Base, this tracking system allows real-time monitoring and surveillance of personnel and assets and has a 200+ square mile coverage. Solar powering capabilities and extend battery life allow the tracker to be used in areas without existing power sources.
  • GPS Rifle Tracker: The company’s smallest GPS tracker, designed to withstand shocks and water submersion due to its robust, military standard enclosure, can be mounted on any AR15 platform picatinny rail to detect weapon discharge, track weapons and inventory, and send time and location alerts.

Led by a management team with solid experience in wearable technology, IoT, consumer electronics, mobile and technology licensing, as well as finance and the footwear industry, GTX plans to leverage its core technology platform to reach new verticals via licensing agreements and strategic partnerships, and to monetize its intellectual property portfolio. The monetization campaign kicked off in 2017 has already identified 100 companies that could become licensees. Besides military and law enforcement, the company also eyes the biometrics market, home health, medicare and insurance and other security applications for potential uses of its IoT platform and tracking technology.

GTX currently has 15 domestic and international distributors, subscribers in 35 countries and more than 700 online affiliates. With multiple revenue streams, several consecutive years of double-digit revenue growth and a strong pipeline of lucrative commercial products, GTX is uniquely positioned to become a leading provider of tracking solutions on this growing multi-billion-dollar market.

GTX Corp (GTXO), closed the day's trading session at $0.08, off by 15.79%, on 89,210 volume with 14 trades. The average volume for the last 60 days is 4,257 and the stock's 52-week low/high is $0.061/$0.6675.

Recent News

chart

SinglePoint, Inc. (OTCQB: SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

SinglePoint Inc. (OTC:SING) provides overall company update including revenue, Form 10, acquisitions. SinglePoint over the past year has been able to successfully integrate its acquisitions and reported revenues of over $188,000 for the first quarter of 2018, which represents a significant increase as compared to the first quarter of 2017.

SinglePoint, Inc. (OTCQB: SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed the day's trading session at $0.0324, up 6.51%, on 6,402,304 volume with 253 trades. The average volume for the last 60 days is 6,740,673 and the stock's 52-week low/high is $0.0235/$0.415.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.